Antibiotice plans production for critical medicines
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.

Delgaz Grid S.A., the electricity and natural gas distribution company of the E.ON România Group, has signed a sustainable refinancing worth RON 3 billion (around €572 million) to meet the company's liquidity needs.
Romania's media market reached an estimated net value of €838 million in 2025, up 5.4% compared to the previous year, according to Media Fact Book 2026, Initiative's annual report.
The Romanian Government has adopted a financing instrument worth RON 5.313 billion (€1 billion) to develop production capacities in Romania.
Holcim has completed the acquisition of Xella, a European walling business with projected 2026 net sales of €1 billion. The acquisition expands Holcim's building solutions portfolio with brands for both new build and the energy-efficient repair and refurbishment market.
The LaDoiPași proximity store network, developed by Metro Romania, has opened 100 stores in a single day and passed the 3,000-store milestone nationwide.